Editorial Board

• Joseph H. Antin, Harvard University, USA
• Igor W. Blau, Charité - Universitätsmedizin Berlin, Germany
• Catherine Bollard, Baylor College of Medicine, USA
• Paolo De Fabritiis, University of Rome “Tor Vergata”, Italy
• Yigal Dror, The Hospital for Sick Children, Canada
• César O. Freytes, The University of Texas Health Science Center at San Antonio, USA
• A. Ganser, Hannover Medical School (MHH), Germany
• Eva C. Guinan, Harvard University, USA
• Kais Hussein, Medizinische Hochschule Hannover, Germany
• Issa F. Khouri, The University of Texas M. D. Anderson Cancer Center, USA
• Hans Klingemann, Tufts Medical Center, USA
• Guido Kobbe, Heinrich-Heine-Universität, Germany
• Hans Jochem Kolb, Ludwig-Maximilians-Universität, Germany
• Robert B. Levy, University of Miami, USA
• Mark R. Litzow, Mayo Clinic, USA
• Fausto Loberiza, University of Nebraska Medical Center, USA
• David Ma, St Vincent's Hospital, Australia
• Ignazio Majolino, Azienda ospedaliera S.Camillo-Forlanini, Italy
• Philip L. McCarthy, Roswell Park Cancer Institute, USA
• Kenneth R. Meehan, Dartmouth Hitchcock Medical Center, USA
• Paul V. O'Donnell, Fred Hutchinson Cancer Research Center, USA
• Helen A. Papadaki, Heraklion University, Greece
• Finn B. Petersen, intermountain Healthcare, USA
• Luis F. Porrata, Mayo Clinic, USA
• Peter J. Quesenberry, Brown University, USA
• Shahin Rafii, Cornell University, USA
• Voravit Ratanatharathorn, Karmanos Cancer Institute, USA
• David A. Rizzieri, Duke University, USA
• Patrick J. Stiff, Loyola University Chicago, USA
• Anna Sureda, Clinical Hematology Division, Hospital de La Santa Creu I Sant Pau, Spain
• Guido J K Tricot, University of Utah, USA
• Celalettin Ustun, Medical College of Georgia, USA
• Catherine Verfaillie, Katholieke Universiteit Leuven, Belgium
• Axel R. Zander, University of Hamburg, Germany